Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Allergy Physician in Sacramento, CA
NPI: 1073524740Primary Practice Location
Capital Allergy and Respiratory Disease Center a Med Corp
5609 J St, Sacramento, CA
Primary Employer
Capital Allergy and Respiratory Disease Center a Med Corp
capitalallergy.com
HQ Phone
Get M.D. Bradley's Phone Numberphone_androidMobile
Get M.D. Bradley's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1979 - 2026
TX State Medical License
1972 - 1991
MD State Medical License
1976 - 1982
American Board of Allergy and Immunology
Allergy & Immunology
American Board of Pediatrics
Pediatrics
UTMB Health
utmb.edu
Medical School
Until 1972
Johns Hopkins University
Fellowship • Allergy and Immunology
1977 - 1978
Residency • Pediatrics
1976 - 1977
University of Texas Medical Branch Hospitals
Residency • Pediatrics
1972 - 1974
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 515 | 866 |
| 2 | 95117Injection of incremental dosages of allergen, 2 or more injections | 303 | 4,419 |
| 3 | 96160Administration and interpretation of patient-focused health risk assessment | 228 | 286 |
| 4 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 204 | 235 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 200 | 253 |
Identifying Patients for Self-Administration of Omalizumab.
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis.
Authors: Jonathan Corren, Nikhil Amin, John Fitzgerald, Nicola Hanania
Journal: Ann Allergy Asthma Immunol
Publication Date: 2020-05-28
What are the determinates of asthma control
Authors: Bradley E. Chipps, Joseph D. Spahn
Publication Date: 2006-10
Lead Sponsor: Sanofi
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Dupilumab, DRUG: Levalbuterol/Levosalbutamol, DRUG: Inhaled corticosteroid (ICS) therapy, DRUG: Albuterol/Salbutamol
Lead Sponsor: Sanofi
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Dupilumab, DRUG: Levalbuterol/Levosalbutamol, DRUG: Oral corticosteroid therapy (prednisone/prednisolone), DRUG: Inhaled corticosteroid (ICS) therapy, DRUG: Albuterol/Salbutamol
